Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option

1.00 hr(s) | CME

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: June 21, 2021

Expiration Date: June 20, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses unmet needs of patients with moderate to severe psoriasis and the clinical potential of targeting the TYK2 pathway as a novel nonbiologic oral therapeutic option.

Access this activity
Share via
Copy link
Powered by Social Snap